| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| Gross margin | 371,9 k € | -7.4% | 401,6 k € | +105.4% | 195,5 k € | |
| EBITDA | 355,7 k € | -11.2% | 400,8 k € | +105.2% | 195,4 k € | |
| Operating profit | 310,3 k € | -14.6% | 363,4 k € | +105.2% | 177,1 k € | |
| Profit/loss | 228,6 k € | -14.9% | 268,6 k € | +100.4% | 134,0 k € | |
| Equity | 422,2 k € | +4.6% | 403,6 k € | +198.9% | 135,0 k € | |
| Total assets | 788,7 k € | +5.7% | 745,9 k € | +47.7% | 505,0 k € | |
| Cash | 200,7 k € | -47.0% | 378,5 k € | +447.7% | 69,1 k € | |
| Debts | 366,4 k € | +7.1% | 342,1 k € | -7.5% | 370,0 k € | |
Source: Belgian Official Gazette
Private limited company profitable and well capitalised. Cash position declining (-47.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Ophtalmogerard is a Private limited company incorporated in 2023. Its main activity is: Specialist medical practice activities. Its registered office is in Seneffe.